Business InMed Pharma rolls out rare cannabinoid via BayMedica D9-THCV one of many in company cannabinoid portfolio set to diversify and expand in coming years Rowan DunneJune 13, 2022
The weed wire Willow Biosciences to get National Research Council funding Funding will go towards commercialization of rare cannabinoids produced from yeast Michelle GamageSeptember 9, 2020